147 related articles for article (PubMed ID: 17268041)
1. Scanning electron microscopic analysis of defects in polymer coatings of three commercially available stents: comparison of BiodivYsio, Taxus and Cypher stents.
Otsuka Y; Chronos NA; Apkarian RP; Robinson KA
J Invasive Cardiol; 2007 Feb; 19(2):71-6. PubMed ID: 17268041
[TBL] [Abstract][Full Text] [Related]
2. Evaluation of balloon withdrawal forces with bare-metal stents, compared with Taxus and Cypher drug-eluting coronary stents: balloon, stent and polymer interactions.
Turk M; Gupta V; Fischell TA
J Invasive Cardiol; 2010 Mar; 22(3):113-6. PubMed ID: 20197577
[TBL] [Abstract][Full Text] [Related]
3. Polymer stent coating for prevention of neointimal hyperplasia.
Billinger M; Buddeberg F; Hubbell JA; Elbert DL; Schaffner T; Mettler D; Windecker S; Meier B; Hess OM
J Invasive Cardiol; 2006 Sep; 18(9):423-6; discussion 427. PubMed ID: 16954581
[TBL] [Abstract][Full Text] [Related]
4. Overlapping paclitaxel-eluting stents: long-term effects in a porcine coronary artery model.
Wilson GJ; Polovick JE; Huibregtse BA; Poff BC
Cardiovasc Res; 2007 Nov; 76(2):361-72. PubMed ID: 17716637
[TBL] [Abstract][Full Text] [Related]
5. Restenosis of the CYPHER-Select, TAXUS-Express, and Polyzene-F nanocoated cobalt-chromium stents in the minipig coronary artery model.
Radeleff B; Thierjung H; Stampfl U; Stampfl S; Lopez-Benitez R; Sommer C; Berger I; Richter GM
Cardiovasc Intervent Radiol; 2008; 31(5):971-80. PubMed ID: 18095019
[TBL] [Abstract][Full Text] [Related]
6. Restenosis following implantation of bare metal coronary stents: pathophysiology and pathways involved in the vascular response to injury.
Scott NA
Adv Drug Deliv Rev; 2006 Jun; 58(3):358-76. PubMed ID: 16733073
[TBL] [Abstract][Full Text] [Related]
7. [Drug-eluting stents for diabetic patients. A critical appraisal of the currently available data from randomized trials].
Silber S; Herdeg C
Herz; 2008 Apr; 33(3):196-205. PubMed ID: 18568314
[TBL] [Abstract][Full Text] [Related]
8. Novel bioabsorbable salicylate-based polymer as a drug-eluting stent coating.
Jabara R; Chronos N; Robinson K
Catheter Cardiovasc Interv; 2008 Aug; 72(2):186-94. PubMed ID: 18651646
[TBL] [Abstract][Full Text] [Related]
9. Local paclitaxel delivery after coronary stenting in an experimental animal model.
Dommke C; Haase KK; Süselbeck T; Streitner I; Haghi D; Metz J; Borggrefe M; Herdeg C
Thromb Haemost; 2007 Sep; 98(3):674-80. PubMed ID: 17849059
[TBL] [Abstract][Full Text] [Related]
10. Scanning electron microscopic assessment of coating irregularities and their precursors in unexpanded durable polymer-based drug-eluting stents.
Basalus MW; Tandjung K; van Westen T; Sen H; van der Jagt PK; Grijpma DW; van Apeldoorn AA; von Birgelen C
Catheter Cardiovasc Interv; 2012 Mar; 79(4):644-53. PubMed ID: 21805599
[TBL] [Abstract][Full Text] [Related]
11. A comparison of clinical and angiographic outcomes after Excel bioabsorbable polymer versus Firebird durable polymer rapamycin-eluting stent for the treatment of coronary artery disease in a "real world" setting: six-month follow-up results.
Liu HB; Xu B; Qiao SB; Yang YJ; Ma WH; Qin XW; Yao M; Wu YJ; Yuan JQ; Chen J; You SJ; Dai J; Xia R; Li JJ; Chen JL; Gao RL
Chin Med J (Engl); 2007 Apr; 120(7):574-7. PubMed ID: 17442205
[TBL] [Abstract][Full Text] [Related]
12. Firebird and cypher sirolimus-eluting stents and bare metal stents in treatment of very long coronary lesions.
Fan L; Chen LL; Lin CG; Peng YF; Zheng XC; Luo YK; Zhang FL; Chen JH; Yan XP; Huang ZR
Chin Med J (Engl); 2008 Aug; 121(16):1518-23. PubMed ID: 18982862
[TBL] [Abstract][Full Text] [Related]
13. Percutaneous coronary intervention utilizing a new endothelial progenitor cells antibody-coated stent: a prospective single-center registry in high-risk patients.
Miglionico M; Patti G; D'Ambrosio A; Di Sciascio G
Catheter Cardiovasc Interv; 2008 Apr; 71(5):600-4. PubMed ID: 18360849
[TBL] [Abstract][Full Text] [Related]
14. Scanning electron microscopic analysis of different drug eluting stents after failed implantation: from nearly undamaged to major damaged polymers.
Wiemer M; Butz T; Schmidt W; Schmitz KP; Horstkotte D; Langer C
Catheter Cardiovasc Interv; 2010 May; 75(6):905-11. PubMed ID: 20088011
[TBL] [Abstract][Full Text] [Related]
15. Drug-eluting coronary stents: many meta-analyses, little benefit.
Prescrire Int; 2009 Apr; 18(100):70-4. PubMed ID: 19585727
[TBL] [Abstract][Full Text] [Related]
16. Long-term biocompatibility evaluation of a novel polymer-coated stent in a porcine coronary stent model.
Huang Y; Liu X; Wang L; Li S; Verbeken E; De Scheerder I
Coron Artery Dis; 2003 Aug; 14(5):401-8. PubMed ID: 12878906
[TBL] [Abstract][Full Text] [Related]
17. Comparison of inflammatory response after implantation of sirolimus- and paclitaxel-eluting stents in porcine coronary arteries.
Wilson GJ; Nakazawa G; Schwartz RS; Huibregtse B; Poff B; Herbst TJ; Baim DS; Virmani R
Circulation; 2009 Jul; 120(2):141-9, 1-2. PubMed ID: 19564562
[TBL] [Abstract][Full Text] [Related]
18. Local vascular toxicokinetics of stent-based drug delivery.
Tesfamariam B
Toxicol Lett; 2007 Jan; 168(2):93-102. PubMed ID: 17169513
[TBL] [Abstract][Full Text] [Related]
19. Incidence of thrombosis after implantation of drug-eluting stents in patients with coronary artery disease.
Chen JL; Yang YJ; Gao LJ; Huang JH; Qin XW; Qiao SB; Xu B; Yao M; Liu HB; Wu YJ; Yuan JQ; Chen J; You SJ; Dai J; Li JJ; Gao RL
Chin Med J (Engl); 2008 Nov; 121(21):2144-7. PubMed ID: 19080174
[TBL] [Abstract][Full Text] [Related]
20. Drug-eluting stent strut distribution: a comparison between Cypher and Taxus by optical coherence tomography.
Suzuki Y; Ikeno F; Yeung AC
J Invasive Cardiol; 2006 Mar; 18(3):111-4. PubMed ID: 16598109
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]